HiGlance Milestones

2003

Founded with the aim of “Quality Medicines for Everyone”, The HiGlance Laboratories registered as a Private Limited Company on 11 June, 2003.

Placeholder image

2004

Foundation Stone laid by HiGlance for first manufacturing plant in Greater Noida, India.

Placeholder image
Placeholder image
2007

Commencement of Product development & Production Started for Tablets & Capsules.

Placeholder image
2008

Marketing Sales & Distribution operation started in India.

Placeholder image
2009

Export Operation Started in CIS Countries with HiGlance own brands.

Placeholder image
2010

Export Operation Started in Latin American Countries.

Placeholder image
2011

Export Operation Started in Russia with own Marketing Sales & Distribution team.

Placeholder image
Placeholder image
2012

Separate wing setup for Research & Development (R&D).

Placeholder image

 

Liquid Oral Plant Started Production.

Placeholder image
2013

HiGlance entered in chain pharmacy segment & started catering to millions of people in India.

Placeholder image
Placeholder image
2015

Collaboration with Reckitt Benckiser (RB), UK for Development & Manufacturing of Nurofen Brand.

Placeholder image

 

HiGlance Laboratories entered into Cardio & Diabetic segment with the launch of "CD Care" division to cater millions of people suffering from Cardio & Diabetes diseases.

Placeholder image
2016

Pellets manufacturing Plant started Production.

Placeholder image
2019

Soft Gelatin Capsule Plant setup.

Placeholder image
2020

Foundation Stone laid by HiGlance for first super-specialty Hospital Chain in India. It will become functional by 2022.

Placeholder image
2021

Launch of first OTC (Over-The-Counter) product PROTANCE (Antacid, Antigas Gel for the treatment of Acidity, Heartburn and Gas) on TVC by appointing renowned actress Raveena Tandon as its brand ambassador. For more information logon www.protance.com

Placeholder image Placeholder image Placeholder image
2024

Foundation Stone laid by HiGlance for second manufacturing plant in Greater Noida, India for STERILE INJECTABLES (Vials, Ampoules, PFS- Pre Filled Syringe, Lyophilized Injection, Eye-Ear Drops, Nasal and Oral Spray). The Facility shall be designed, engineered and validated in compliance to WHO, PIC/S and EUGMP, USFDA regulatory guidelines.

Placeholder image